Metabolism of styrene in the human liver in vitro: interindividual variation and enantioselectivity

References

• ARLIEN-SOBORG, P., 1992, Styrene. In P. Arlien-Soborg, Solvent Neurotoxicity (Boca Raton: CRC Press), pp. 129–153.
   Google Scholar
• BARALE, R., 1991, The genetic toxicology of styrene and styrene oxide. Mutation Research, 257, 107-126. BELLUCCI, G., CHIAPPE, C., CORDONI, A. and MARIONI, F., 1994, Enantioselectivity in the rabbit liver microsomal biotransformation of styrene and phenylpropenes. Biocatalysis, 10, 149–157.
   Google Scholar
• BOND, J. A., 1989, Review of the toxicology of styrene. CRC Critical Reviews in Toxicology, 19,227–249.
   Web of Science ®Google Scholar
• CARRIERE, V., BERTHOU, F., BAIRD, S., BELLOC, C., BEAUNE, P. and WAZIERS DE, I., 1996, Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics, 6, 203–211.
   PubMedGoogle Scholar
• CHANG, T. K. H., GONZALEZ, F. J. and WAXMAN, D. J., 1994, Evaluation of triacetyloleandomycin, a-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Archives of Biochemistry and Biophysics, 311, 437–442.
   Google Scholar
• CHERRY, N. and GAUTRIN, D., 1990, Neurotoxic effects of styrene: further evidence. British Journal of Industrial Medicine, 47, 29–37.
   PubMedGoogle Scholar
• CHIAPPE, C., DE RUBERTIS, A., AMATO, G. and GERVASI, P. G., 1998, Stereochemistry of the biotransformation of 1-hexene and 2 -methy1-1-hexene with rat liver microsomes and purified P450 of rats and humans. Chemical Research in Toxicology, 11, 1487–1493.
   PubMedGoogle Scholar
• CLARKE, S. E., 1998, In vitro assessment of human cytochrome P450. Xenobiotica, 28, 1167–1202.
   PubMed Web of Science ®Google Scholar
• FOUREMAN, G. L., HARRIS, C., GUENGERICH, F. P. and BEND, J. R., 1989, Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver. Journal of Pharmacology and Experimental Therapeutics, 248, 492–497.
   PubMed Web of Science ®Google Scholar
• GADBERRY, M. G., DENICOLA, D. B. and CARLSON, G. P., 1996, Pneumotoxicity and hepatotoxicity of styrene and styrene oxide. Journal of Toxicology and Environmental Health, 48, 273–294.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., KIM, D. H. and IwAsmu, M., 1991, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chemical Research in Toxicology, 4, 168–179.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P. and TURVY, C. G., 1991, Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immuno - chemical analysis of surgical liver samples. Journal of Pharmacology and Experimental Thera-peutics, 256, 1189–1194.
   PubMed Web of Science ®Google Scholar
• HAYASHI, S., WATANABE, J. and KAWAJIRI, K., 1991, Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P4501IE1 gene. Journal of Bio-chemistry, 110, 559–565.
   Google Scholar
• HICKMAN, D., WANG, J.-P., WANG, Y. and UNADKAT, J. D., 1998, Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metabolism and Disposition, 26, 207–215.
   Google Scholar
• HILDESHEIM, A., CHEN, C.-J., CAPORASO, N. E., CHENG, Y.-J., HOOVER, R. N., Hsu, M.-M., LEVINE, P. H., CHEN, I.-H., CHEN, J.-Y., YANG, C. S., DALY, A. K. and IDLE, J. R., 1995, Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: Results from a case-control study conducted in Taiwan. Cancer Epidemiology, Biomarkers and Prevention, 4, 607–610.
   Google Scholar
• Hu, Y., OSCARSON, M., JOHANSSON, I., Yu, Q.-Y., DAHL, M.-L., TABONE, M., ARINCO, S., ALBANO, E. and INGELMAN-SUNDBERG, M., 1997, Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Molecular Pharmacology, 51, 370–376.
   Google Scholar
• IARC, 1994, Styrene-7,8-oxide. I ARC Monographs on the Evaluation of Carcinogenic Risk to Humans, 60, 321–346.
   PubMedGoogle Scholar
• KOué, S., JAKASA, I., WENKER, M. A. M., BOOGAARD, P. J., MONSTER, A. C. and WOLFF DE, F. A., 2000, Journal of Chromatography B, 749, 265–274.
   Google Scholar
• KIM, H., WANG, R. S., ELOVAARA, E., RAUNIO, H., PELKONEN, O., AOYAMA, T., VAINIO, H. and NAKAJIMA, T., 1997, Cytochrome P450 isoenzymes responsible for the metabolism of toluene and styrene in human liver microsomes. Xenobiotka, 27, 657–665.
   PubMed Web of Science ®Google Scholar
• KOOP, D. R., 1986, Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isoenzyme 3a. Molecular Pharmacology, 29, 399–404.
   PubMed Web of Science ®Google Scholar
• LILIS, R., LORIMER, W. V., DIAMOND, S. and SELIKOFF, I. J., 1978, Neurotoxicity of styrene in production and polymerization workers. Environmental Research, 15, 133–138.
   PubMed Web of Science ®Google Scholar
• LUCAS, D., MENEZ, C., GIRRE, C., BERTHOU, F., BODENEZ, P., JOANNET, I., HISPARD, E., BARDOU, L. and MENEZ, J., 1995, Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics, 5, 298–304.
   PubMedGoogle Scholar
• MENDRALA, A. L., LANGVARDT, P. W., NITSCHKE, K. D., QUAST, J. F. and NOLAN, R. J., 1993, In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human. Archives of Toxicology, 67, 18–27.
   PubMed Web of Science ®Google Scholar
• MUTTI, A., MAZZUCCHI, A., RUSTICHELLI, P., GRAZIANO, F., ARFINI, G. and FRANCHIN I., 1984, Exposure-effect and exposure-respon relationships between occupational exposure to styrene and neuropsychological functions. American Journal of Industrial Medicine, 5, 275–286.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA, T., ELOVAARA, E., GONZALEZ, F. J., GELBOIN, H. V., RAUNIO, H., PELKONEN, O., VAINIO, H. and AOYAMA, T., 1994, Styrene metabolism by cDNA-expressed human hepatic and pulmonary cytochromes P450. Chemical Research in Toxicology, 7, 891–896.
   PubMed Web of Science ®Google Scholar
• NAKAJIMA, T., ELOVAARA, E., GONZALEZ, F. J., GELBOIN, H. V., VAINIO, H. and AOYAMA, T., 1993, Characterization of the human cytochrome P450 isoenzymes responsible for styrene metabolism. IARC Scientific Publications, 127, 101–108.
   Google Scholar
• NEWTON, D. J., WANG, R. W. and Lu, A. Y. H., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• ONO, S., HATANAKA, T., HOTTA, H., SATOH, T., GONZALEZ, F. J. and TSUTSUI, M., 1996, Specificity of substrate and inhibitor probes for cytochrome P450: evaluation of in vitro metabolism using cDNA-expressed human P450 and human liver microsomes. Xenobiotica, 26, 681–693.
   PubMed Web of Science ®Google Scholar
• PIRMOHAMED, M., KITTERINGHAM, N. R., QUEST, L. J., ALLOTT, R. L., GREEN, V. J., GILMORE, I. T. and PARK, B. K., 1995, Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetks, 5, 351–357.
   PubMedGoogle Scholar
• POWELL, H., KITTERINGHAM, N. R., PIRMOHAMED, M., SMITH, D. A. and PARK, B. K., 1998, Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype. Pharmacogenetics, 8, 411–421.
   PubMedGoogle Scholar
• REBERT, C. S. and HALL, T. A., 1994, The neuroepidemiology of styrene: a critical review of representative literature. CRC Critical Reviews in Toxicology, 24, S57—S106.
   Google Scholar
• ROSENGREN, L. E. and HAGLID, K. G., 1989, Long term neurotoxicity of styrene. A quantitative study of glial acidic protein (GFA) and S-100. British Journal of Industrial Medicine, 46, 316–320.
   PubMedGoogle Scholar
• SEILER, J. P., 1990, Chirality-dependent DNA reactivity as the possible cause of the differential mutagenicity of the two components in an enantiomeric pair of epoxides. Mutation Research, 245, 165–169.
   PubMed Web of Science ®Google Scholar
• SUMNER, S. J. and FENNELL, T. R., 1994, Review of the metabolic fate of styrene. Critical Reviews in Toxicology, 24, S11—S33.
   Google Scholar
• UEMATSU, F., IKAWA, S., KIKUCHI, H., SAGAMI, I., KANAMARU, R., ABE, T., SATOH, K., MOTOMIYA, M. and WATANABE, M., 1994, Restriction fragment length polymorphism of the human CYP2E1 (cytochrome-P450IIE1) gene and susceptibility to lung cancer — possible relevance to low smoking exposure. Pharmacogenetks, 4, 58–63.
   PubMedGoogle Scholar
• UEMATSU, F., KIKUCHI, H., MOTOMIYA, M., ABE, T., SAGAMI, I., OHMACHI, T., WAKUI, A., KANAMARU, R. and WATANABE, M., 1991, Association between restriction fragment polymorphism of the human P450I1E1 gene and susceptibility to lung cancer. Japanese Journal of Cancer Research, 82, 254–256.
   PubMedGoogle Scholar
• WATABE, T., OZAWA, N. and HIRATSUK A., 1983, Studies OR metabolism and toxicity of styrene — VI. regioselectivity in glutathione S-conjugation and hydrolysis of racemic, R- and S-phenyloxiranes in rat liver. Biochemical Pharmacology, 32, 777–785.
   PubMed Web of Science ®Google Scholar
• WATANABE, J., HAYASHI, S. and KAWAJIRI, K., 1994, Different regulation and expression of the human CYP2E1 gene due to the Rsal polymorphism in the 5'-flanking region. Journal of Biochemistry, 116, 321–326.
   PubMed Web of Science ®Google Scholar
• WELP, E., KOGEVINAS, M., ANDERSEN, A., BELLANDER, T., BIOCCA, M., COGGON, D., ESTEVE, J., GENARRO, V., KOLSTAD, H., LUNDBERG, I., LYNGE, E., PARTANEN, T., SPENCE, A., BOFFETTA, P., FERRO, G. and SARACCI, R., 1996, Exposure to styrene and mortality from nervous system diseases and mental disorders. American Journal of Epidemiology, 144, 623–633.
   PubMed Web of Science ®Google Scholar
• WENKER, M. A. M., KOIC, S., MONSTER, A. C. and WOLFF DE, F. A., 2000, Metabolism of styrene-7,8-oxide in human liver in vitro: interindividual variation and stereochemistry. Toxicology and Applied Pharmacology, 169, 52–58.
   Google Scholar
• WISTUBA, D., NOWOTNY, H. P., TRAGER, O. and SCHURIG, V., 1989, Cytochrome P-450-catalyze1 asymmetric epoxidation of simple prochiral and chiral aliphatic alkenes : Species dependence and effect of enzyme induction on enantioselective oxirane formation. Chirality, 1, 127–136.
   PubMed Web of Science ®Google Scholar